1 / 13

Clinical Risk Communication

Clinical Risk Communication. Dr. Engel. Sources of Distortion. Outside Noise. Receiver Noise. Signal Noise. Transmitter Noise. Outside Noise. voluntary  coerced natural  industrial familiar  not memorable  not dreaded  not catastrophic  chronic. knowable  not

adena-mendoza
Download Presentation

Clinical Risk Communication

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Risk Communication Dr. Engel

  2. Sources of Distortion OutsideNoise Receiver Noise Signal Noise Transmitter Noise Outside Noise

  3. voluntary coerced natural industrial familiar not memorable not dreaded not catastrophic chronic knowable not controlled not fair unfair morally relevant not trust not response not Components of Outrage

  4. Building Trust Empathy--Caring Competence--Expertise Commitment--Dedication Honesty--Openness

  5. Some Common Pitfalls Jargon Humor Confrontation Worst-case scenarios Cost comparisons Describing the differential Shotgun testing Compare risks

  6. Stepped Approach to Risk Communication Medically Unexplained Symptoms Symptom-based patient education Consult Deployment Health Clinical Center Consider Specialized Care Program Well-Defined Disease Disease-based patient education Disease prognosis Disease treatment options Concerned, Asymptomatic Unconcerned, Recently Deployed Deployment patient education (PDHealth.mil) 30 minute follow-up visit ‘Routine’ rapport & trust-building

  7. Medically Unexplained Symptoms Well-Defined Disease Concerned, Asymptomatic Unconcerned, Post-Deployed Stepped Approach to Risk Communication

  8. Stepped Approach to Risk Communication Concerned, Asymptomatic Medically Unexplained Symptoms Well-Defined Disease • Deployment-based patient education • Deployment-based provider education • 30 minute follow-on visit Unconcerned, Post-Deployed

  9. Stepped Approach to Risk Communication Well-Defined Disease Medically Unexplained Symptoms • Disease-based patient education • Disease prognosis • Disease-based treatment options • Disease-based self-care Concerned, Asymptomatic Unconcerned, Post-Deployed

  10. Stepped Approach to Risk Communication Medically Unexplained Symptoms • Symptom-based patient education • Intensive symptom-based self care instruction • Consult Deployment Health Clinical Center • Consider Specialized Care Program Well-Defined Disease Concerned, Asymptomatic Unconcerned, Post-Deployed

  11. Arnold LM, Keck PE, Wel JW. Antidepressant treatment of fibromyalgia: A meta-analysis and review. Psychosomatics 2000; 41 (2):104-113. • Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 1994; 154:2049-53. • Working Group of the Royal Australasian College of Physicians. Chronic fatigue syndrome. Clinical practice guidelines--2002. Med J Aust 176:S17-56 (2002). Available: http://www.mja.com.au/au/public/guides/cfs/cfs2.pdf. • Demitrack MA. Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management. Psychiatric Clinics of North America 1998; 21:671-92 • Engel Jr CC, Katon WJ. Population and need-based prevention of unexplained symptoms in the community. IOM Strategies to Protect the Health of Deployed U.S. Forces. Washington DC: Institutes of Medicine: 1999; 173-212. • Hunt SC, Richardson RD, Engel CC Jr. Clinical management of Gulf War veterans with medically unexplained physical symptoms. Mil Med 2002; 167(5):414-420 • Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue syndrome: a systematic review. QJM 1997; 90:723-5. • Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials. Psychother Psychosom 2000; 69(4):205-15. • Kroenke K, Spitzer RL, Williams JB. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch of Fam Med 1994; 3(9):774-9. • Kroenke K, Price RK. Symptoms in the community: prevalence, classification, and psychiatric comorbidity. Arch Intern Med 1993; 153:2474-80. • Leventhal LJ. Management of fibromyalgia. Ann Int Med 1999; 131:850-8. • O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: A meta-analysis. J Gen Intern Med 2000; 15(9):659-66. • O'Malley PG, Jackson JL, Tomkins G, Santoro J, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes: A critical review. J Fam Pract 1999; 48:980-93. • Price JR, Cooper J. Cognitive behaviour therapy for adults with chronic fatigue syndrome. The Cochrane Library 1998(4). • Reid S, Chalder T, Cleare A, Hotopf M, Wessely S. Chronic Fatigue Syndrome. BMJ 2000; 320(7230):292-96. • Walker EA, Unutzer J, Katon WJ. Understanding and caring for the distressed patient with multiple medically unexplained symptoms. J Am Board Fam Pract 1998; 11(5):347-56.

More Related